Dr. Martens (LON:DOCS) Trading 25.8% Higher - Should You Buy?

Dr. Martens plc (LON:DOCS - Get Free Report) shares shot up 25.8% during mid-day trading on Thursday . The stock traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). 8,364,149 shares changed hands during trading, an increase of 271% from the average session volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada lowered their target price on shares of Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating for the company in a research note on Monday, May 19th.

Dr. Martens Stock Performance

The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The stock has a market capitalization of £764.48 million, a PE ratio of 11.16, a PEG ratio of 6.40 and a beta of 0.11. The firm has a 50 day moving average price of GBX 54.73 and a 200-day moving average price of GBX 62.64.

Dr. Martens (LON:DOCS - Get Free Report) last issued its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. Research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Dr. Martens Cuts Dividend

The firm also recently announced a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were issued a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's dividend payout ratio (DPR) is presently 42.53%.

Insider Activity at Dr. Martens

In other news, insider Giles Wilson bought 32,640 shares of the firm's stock in a transaction that occurred on Tuesday, March 25th. The stock was purchased at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,934.82). Insiders acquired 33,206 shares of company stock worth $1,792,771 over the last three months. Company insiders own 4.36% of the company's stock.

Dr. Martens Company Profile

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.